Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
31 studies found for:    Open Studies | "Adrenal Gland Neoplasms"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Not yet recruiting Combined FDG-PET and 123I-Iodometomidate Imaging for Adrenal Neoplasia
Condition: Adrenal Gland Neoplasms
Interventions: Other: FDG positron emission tomography;   Other: Iodometomidate imaging
2 Recruiting Evaluation of Molecular Markers in Adrenal Tumors
Condition: Adrenal Gland Neoplasms
Intervention:
3 Recruiting Study of Adrenal Gland Tumors
Condition: Adrenal Gland Neoplasm
Intervention:
4 Recruiting Towards an Easy-to-use Adrenal Cancer/Tumor Identity Card
Condition: Adrenal Gland Neoplasms
Intervention: Biological: omics identity card
5 Recruiting Adrenalectomy Versus Follow-up in Patients With Subclinical Cushings Syndrome
Condition: Adrenal Tumour With Mild Hypercortisolism
Intervention: Procedure: Adrenalectomy
6 Recruiting Adrenal Tumors - Pathogenesis and Therapy
Conditions: Adrenal Tumors;   Adrenocortical Carcinoma;   Cushing Syndrome;   Conn Syndrome;   Pheochromocytoma
Intervention:
7 Recruiting Structured Evaluation of adRENal Tumors Discovered Incidentally - Prospectively Investigating the Testing Yield
Conditions: Adrenal Incidentaloma;   Adrenocortical Carcinoma
Intervention:
8 Recruiting Adrenal Venous Sampling in Patients With Overt or Subclinical Cushings Syndrome, and Bilateral Adrenal Tumors
Condition: Cushing Syndrome
Intervention: Radiation: Adrenal venous sampling
9 Recruiting Surgery of Subclinical Cortisol Secreting Adrenal Incidentalomas
Condition: Adrenal Incidentalomas
Interventions: Procedure: Laparoscopic surgical removal of the adrenal tumor;   Drug: Standardized medical treatment of hypertension by SAHR
10 Recruiting An Image-guided SBRT for Adrenal Gland Metastasis in Oligometastatic Patients
Condition: Adrenal Gland Metastases
Intervention: Radiation: Stereotactic Body Radiation Therapy
11 Recruiting Efficacy and Safety of Posterior Retroperitoneoscopic Adrenalectomy: A Comparative Study
Conditions: Adrenal Mass;   Adrenal Disease;   Pheochromocytoma;   Cushing Syndrome
Interventions: Procedure: Posterior retroperitoneoscopic adrenalectomy;   Procedure: Transperitoneal laparoscopic adrenalectomy
12 Recruiting Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
Conditions: Endocrine Neoplasms;   Thyroid Neoplasms;   Parathyroid Neoplasms;   Adrenal Neoplasm;   Neuroblastoma
Intervention:
13 Recruiting EUS-B-FNA vs EUS-FNA for Left Adrenal Gland Analysis in Lung Cancer Patients
Condition: Suspected Left Adrenal Gland Metastasis in Lung Cancer
Intervention: Procedure: EUS-B-FNA followed by EUS-FNA for LAG analysis
14 Recruiting Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma
Conditions: Adrenocortical Carcinoma;   Adrenal Cancer;   ACC
Intervention: Drug: ATR-101
15 Recruiting Long-term Beneficial Metabolic Effects of Adrenalectomy in Subclinical Cushing's Syndrome of Adrenal Incidentaloma
Condition: Cushing Syndrome
Intervention: Procedure: surgery
16 Recruiting Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism
Conditions: Hypercortisolism;   Cushing Syndrome
Interventions: Procedure: Adrenalectomy;   Other: Observation
17 Not yet recruiting Expression of Different Proliferation Biomarkers in Adreno-cortical Tumors
Conditions: Adrenal Cortex Neoplasms;   Adrenal Cortex Diseases
Intervention:
18 Recruiting International Pediatric Adrenocortical Tumor Registry
Condition: Adrenocortical Tumor
Intervention:
19 Recruiting Nivolumab in Treating Patients With Metastatic Adrenocortical Cancer
Conditions: Metastatic Carcinoma in the Adrenal Cortex;   Recurrent Adrenal Cortex Carcinoma;   Stage III Adrenal Cortex Carcinoma;   Stage IV Adrenal Cortex Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Nivolumab
20 Recruiting Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma
Condition: Adrenocortical Carcinoma
Intervention: Drug: Pembrolizumab

   Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.